12 results
DEF 14A
NAMS
NewAmsterdam Pharma Company N.V.
9 May 24
Definitive proxy
4:15pm
, the Compensation Committee engaged an independent external consultant, Aon’s Human Capital Solutions Practice, a division of Aon plc (“Aon”), to advise
PRE 14A
NAMS
NewAmsterdam Pharma Company N.V.
29 Apr 24
Preliminary proxy
5:00pm
external consultant, Aon’s Human Capital Solutions Practice, a division of Aon plc (“Aon”), to advise on overall compensation matters for all employees
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company N.V.
28 Feb 24
Annual report
8:00am
Pharmaceuticals, Verve Therapeutics and others, that are intended to treat CVD.
Employees and Human Capital Resources
As of December 31, 2023, we had 29
424B3
NAMS
NewAmsterdam Pharma Company N.V.
15 Aug 23
Prospectus supplement
4:52pm
. Drugs must be distributed in China by licensed drug distributors.
Employees and Human Capital Resources
As of June 30, 2023, we had 22 full-time
POS AM
NAMS
NewAmsterdam Pharma Company N.V.
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
in accordance with GMP and meet their home country’s requirements. Drugs must be distributed in China by licensed drug distributors.
Employees and Human … Capital Resources
As of June 30, 2023, we had 22 full-time employees, consisting of clinical, research and development, business development
424B3
loy4 rvgcez
8 Jun 23
Prospectus supplement
5:01pm
424B3
b764on zjo8vw
6 Jun 23
Prospectus supplement
4:20pm
424B3
km3u66st2w4jl1eyojva
25 Apr 23
Prospectus supplement
8:14am
POS AM
ts2li xi0nqfu
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
onuuki6n19p6xh
19 Dec 22
Registration statement (foreign)
6:22pm
20-F
fw9ayr wrgaxdiixog3f
28 Nov 22
Annual report (foreign)
4:41pm
- Prev
- 1
- Next